RICHARD /CA/ MURRAY Insider Trading $JNCE Jounce Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD /CA/ MURRAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD /CA/ MURRAY. RICHARD /CA/ MURRAY is Sr. VP & CSO in PDL BIOPHARMA, INC. ($PDLI) and Sr. VP & CSO in PDL BIOPHARMA, INC. ($PDLI) and SVP & CSO in PDL BIOPHARMA, INC. ($PDLI) and CEO and President in Jounce Therapeutics, Inc. ($JNCE).
RICHARD /CA/ MURRAY in Jounce Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RICHARD /CA/ MURRAY: CEO and President
Holdings: 215,371 shares
Current Value: $3,725,918
Latest Transaction: Feb 03 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD /CA/ MURRAY in Jounce Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 12.67 | 15,000 | 190,050 | 15,000 | |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 11.89 | 150,000 | 1,783,500 | 150,000 | |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 7,500 | 0 | 222,871 | 215.4 K to 222.9 K (+3.48 %) |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 75,000 | 0 | 215,371 | 140.4 K to 215.4 K (+53.43 %) |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 33,518 | 16,089 | 665,169 | |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 12.06 | 33,518 | 404,227 | 140,371 | 173.9 K to 140.4 K (-19.28 %) |
| Jan 25 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 33,518 | 16,089 | 173,889 | 140.4 K to 173.9 K (+23.88 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,482 | 7,911 | 698,687 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 40,000 | 19,200 | 715,169 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 30,000 | 14,400 | 755,169 | |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 12.04 | 16,482 | 198,443 | 140,371 | 156.9 K to 140.4 K (-10.51 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,482 | 7,911 | 156,853 | 140.4 K to 156.9 K (+11.74 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 9.59 | 40,000 | 383,600 | 140,371 | 180.4 K to 140.4 K (-22.18 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 40,000 | 19,200 | 180,371 | 140.4 K to 180.4 K (+28.50 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 8.54 | 30,000 | 256,200 | 140,371 | 170.4 K to 140.4 K (-17.61 %) |
| Jan 20 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 30,000 | 14,400 | 170,371 | 140.4 K to 170.4 K (+21.37 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.00 | 11,816 | 82,712 | 140,371 | 152.2 K to 140.4 K (-7.76 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 6.76 | 10,183 | 68,837 | 152,187 | 162.4 K to 152.2 K (-6.27 %) |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 6.55 | 150,010 | 982,566 | 150,010 | |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 75,010 | 0 | 162,370 | 87.4 K to 162.4 K (+85.86 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.78 | 7,150 | 55,627 | 87,360 | 94.5 K to 87.4 K (-7.57 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 7.78 | 7,150 | 55,627 | 87,360 | 94.5 K to 87.4 K (-7.57 %) |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 40,000 | 19,200 | 785,169 | |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 8.37 | 40,000 | 334,800 | 94,510 | 134.5 K to 94.5 K (-29.74 %) |
| Dec 26 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 40,000 | 19,200 | 134,510 | 94.5 K to 134.5 K (+42.32 %) |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 4.40 | 125,010 | 550,044 | 125,010 | |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Grant | A | 0.00 | 62,510 | 0 | 94,510 | 32 K to 94.5 K (+195.34 %) |
| Sep 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 32,000 | 15,360 | 825,169 | |
| Sep 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 32,000 | 15,360 | 32,000 | 0 to 32 K |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 857,169 | |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 25.10 | 16,334 | 409,983 | 0 | 16.3 K to 0 (-100.00 %) |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 873,503 | |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 22.06 | 4,234 | 93,402 | 0 | 4.2 K to 0 (-100.00 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 21.21 | 12,100 | 256,641 | 4,234 | 16.3 K to 4.2 K (-74.08 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
| Feb 05 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | A | 23.98 | 200,000 | 4,796,000 | 200,000 |
Page: 1